Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-001203
Filing Date
2022-02-10
Accepted
2022-02-10 19:32:01
Documents
1
Period of Report
2022-02-09

Document Format Files

Seq Description Document Type Size
1 form4-02102022_040248.html 4  
1 form4-02102022_040248.xml 4 3914
  Complete submission text file 0001415889-22-001203.txt   5411
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD CO 80112
Business Address
Bar-Or David (Reporting) CIK: 0001530630 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 22616041